Why should people living with HIV and other immunocompromising conditions be included in clinical trials similar to the RBDCOV trial?
Shed light on immunocompromised clinical trials inclusion. 🦠 Why involve those with HIV?
Join our conversation with Juanfran C and Arda from EATG to understand better the significance for a more inclusive and effective future.
Ficha técnica
- Programa
- FrecuenciaSerie completa
- Publicación21 de noviembre de 2023, 18:09 UTC
- Duración8 min
- Episodio6
- ClasificaciónApto